Natco Pharma, based in Hyderabad, is set to acquire a 35.75% stake in Adcock Ingram, South Africa's second-largest drugmaker, for ₹2,000 cr...

Natco Pharma has made a firm offer to acquire nearly 36% stake in South African drug firm Adcock Ingram Holdings for up to Rs 2,100 crore. ...

Another mid-sized pharma firm, La Renon, backed by Sequoia Capital and A91 Partners is also keen on buying out Oaknet. Binding bids will be...

"Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the de...

South Africa’s second largest drug maker Adcock Ingram is in advanced talks to sell part of its India business to Oaknet Lifesciences.

Adcock, which had acquired unlisted Cosme in 2012 for Rs 480 crore, has initiated the process of selling it, they said.

“The Meiji Group wants to enter the global generics field, particularly in Asia and emerging countries,” said the company press release.

South Africa-based drug maker Adcock Ingram has quietly acquired privately-held Cosme Farma for Rs 480 crore, a 13 times premium over Cosme...

South African company Adcock Ingram's plans to buy Cipla Medpro, with whom Cipla has a 20-year drug-supply agreement, has run into trouble ...